This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
4 - 6 June, 2024
Excel London Platinum Suite

Anna M. Wu, Ph.D.
Professor and Chair, Immunology and Theranostics at Beckman Research of the City of Hope


Anna M. Wu, Ph.D, is Professor and Chair, Department of Immunology and Theranostics and Co-Director, Center for Theranostic Studies, Beckman Research of the City of Hope. She previously served as Professor and Vice Chair, Department of Molecular and Medical Pharmacology, Geffen School of Medicine at UCLA, where she served as Director, Cancer Molecular Imaging Program, Jonsson Comprehensive Cancer Center and Co-Associate Director, Crump Institute for Molecular Imaging. Dr. Wu’s research interests include engineered antibodies and proteins for targeting, imaging, and therapeutic applications in cancer and immunology, including the use of SPECT, PET, optical and multimodality approaches. She is the Co-Founder of ImaginAb, Inc., which develops and commercializes radiolabeled antibodies for clinical applications.

Agenda Sessions

  • Delivering Light and Heat Using Engineered Antibodies and Fragments: ImmunoPET and Radioimmunotherapy

  • Co-Chairs' Remarks